Journal for ImmunoTherapy of Cancer (Nov 2023)
599 Single-agent safety and activities of target-preserving anti-CTLA-4 antibody gotistobart (ONC-392/BNT316) in PD-(L)1 resistant metastatic NSCLC and population PK analysis in patients with solid tumors
- Yang Liu,
- Dan Chen,
- Mark Goldstein,
- John Yang,
- Mei Tang,
- Rohit Joshi,
- David Carbone,
- Siwen Hu-Lieskovan,
- Zihai Li,
- Tianhong Li,
- Meredith McKean,
- Kai He,
- Julio Peguero,
- Pan Zheng,
- Hung-Yen Chou,
- Edward Arrowsmith,
- John Hamm,
- AIwu He,
- Satish Shah,
- Alexander I Spira,
- Rama Balaraman,
- Adriana millillo-Naranine
Affiliations
- Yang Liu
- Department of Emergency Medicine, Tianjin Medical University General Hospital, Tianjin, China
- Dan Chen
- 1 Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Ministry of Education-Shanghai Key Laboratory of Children’s Environmental Health, Shanghai, China
- Mark Goldstein
- 2 NCH Physician Group, Naples, Florida, USA
- John Yang
- 19JP Global Pharma LLC, Rockville, MD, USA
- Mei Tang
- Department of Rheumatology and Immunology, Second Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
- Rohit Joshi
- Faculty of Health and Medical Sciences, The University of Adelaide, Adelaide, South Australia, Australia
- David Carbone
- Aff2 grid.152326.10000000122647217Vanderbilt University Nashville TN USA
- Siwen Hu-Lieskovan
- Department of Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah, USA
- Zihai Li
- Department of Medicine, Division of Hematology/Oncology, Ohio State Wexner Medical Center, Columbus, Ohio, USA
- Tianhong Li
- Aff98 grid.27860.3b0000000419369684University of California Davis Comprehensive Cancer Center Sacramento CA USA
- Meredith McKean
- Aff6 0000 0001 2291 4776grid.240145.6Division of Cancer MedicineUniversity of Texas MD Anderson Cancer Center 77030 Houston TX USA
- Kai He
- 2 Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, Minnesota, USA
- Julio Peguero
- 8Oncology Consultants, P.A., Houston, Texas, USA
- Pan Zheng
- Division of Immunotherapy, Institute of Human Virology, University of Maryland School of Medicine, Baltimore, Maryland, USA
- Hung-Yen Chou
- 1OncoC4, Inc., Rockville, MD, USA
- Edward Arrowsmith
- Sarah Cannon Research Institute/Tennessee Oncology, PLLC, Chattanooga, Tennessee, USA
- John Hamm
- 11Norton Healthcare, Louisville, KY, USA
- AIwu He
- 3Georgetown University, Washington DC, USA
- Satish Shah
- 2Pennsylvania Cancer Specialists, Gettysburg, PA, USA
- Alexander I Spira
- 2Next Oncology, Fairfax, VA, USA
- Rama Balaraman
- 6Florida Cancer Affiliates-US Oncology, Ocala, FL, USA
- Adriana millillo-Naranine
- 10Memorial Cancer Institute, Pembroke, FL, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0599
- Journal volume & issue
-
Vol. 11,
no. Suppl 1
Abstract
No abstracts available.